Hepcidin knockout mice developed hyperferremia with a profound susceptibility to bacteremia from Klebsiella pneumoniae, Yersinia enterocolitica, and E. coli, and treatment with a hepcidin analogue restored hypoferremia, decreased bacterial burden, and improved survival in each model of infection [5,55,56]. Here, HAMP is linked to infection.